Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

Erlotinib will be given at a dose of 150 mg per day for 4 weeks before undergoing planned radical cystectomy. In addition, patients will continue on erlotinib daily at a dose of 150 mg per day (qd dosing) for up to 2 years after surgery (beginning within 12 weeks of surgery) or until evidence of disease recurrence or progression

Will occur 4 weeks prior to dosing with erlotinib